Bioengineering 3D environments for cancer models

Advanced Drug Delivery Reviews

Volumn 79, Issue , 2014, Pages 40-49

  Alemany Ribes, Mireia ^a   Semino, Carlos E ^a  

^a Institut Químic de Sarrià Universitat Ramon Llull   (Spain)

Author keywords

Biomaterials; Cancer models; Drug resistance; Drug screening; Nanotechnology; Three dimensional culture; Tumor tissue engineering; Tumorigenesis

Indexed keywords

BIOMATERIALS; CLINICAL RESEARCH; DISEASES; NANOTECHNOLOGY; TISSUE ENGINEERING; TUMORS;

CANCER MODELS; DRUG RESISTANCE; DRUG SCREENING; THREE-DIMENSIONAL CULTURE; TUMOR TISSUES; TUMORIGENESIS;

DIAGNOSIS;

BIOMATERIAL; MACROGOL; POLYGLACTIN; POLYLACTIC ACID; POLYMER; SCLEROPROTEIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; BINDING SITE; BIOENGINEERING; BIOMIMETICS; CANCER CELL; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER MODEL; CANCER RESEARCH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CIRCULATION; DEGRADATION; DRUG RESISTANCE; DRUG SCREENING; EARLY DIAGNOSIS; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; HIGH THROUGHPUT SCREENING; HYDROGEL; HYDROPHILICITY; METASTASIS; METASTASIS POTENTIAL; NANOTECHNOLOGY; PREDICTIVE VALUE; PROCESS OPTIMIZATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; REPRODUCIBILITY; REVIEW; SIGNAL TRANSDUCTION; SOLID PHASE SYNTHESIS; THREE DIMENSIONAL CANCER CELL CULTURE; TISSUE ENGINEERING; TISSUE SCAFFOLD; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; TUMOR TISSUE ENGINEERING; TUMOR VASCULARIZATION; ANIMAL; BIOLOGICAL MODEL; CANCER STAGING; DISEASE COURSE; HUMAN; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION;

ANIMALS; BIOENGINEERING; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TISSUE ENGINEERING;

EID: 84919691161     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.06.004     Document Type: Review

References (125)

1. Pampaloni F., Reynaud E.G., Stelzer E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 2007, 8:839-845. 10.1038/nrm2236.
2. Smalley K.S.M., Lioni M., Herlyn M. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell. Dev. Biol. Anim. 2006, 42:242-247.
3. Hutmacher D.W., Horch R.E., Loessner D., Rizzi S., Sieh S., Reichert J.C., et al. Translating tissue engineering technology platforms into cancer research. J. Cell. Mol. Med. 2009, 13:1417-1427. 10.1111/j.1582-4934.2009.00853.x.
4. Griffith L.G., Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 2006, 7:211-224. 10.1038/nrm1858.
5. Castells-Sala C., Alemany-Ribes M., Fernández-Muiños T., Recha-Sancho L., López-Chicón P., Aloy-Reverté C., et al. Current applications of tissue engineering in biomedicine. J. Biochip Tissue Chip. 2013, S2:1-14. 10.4172/2153-0777.S2-004.
6. Gurski L.A., Petrelli N.J., Jia X., Farach-Carson M.C. 3D matrices for anti-cancer drug testing and development. Oncol. Issues 2010, 20-25.
7. Burdett E., Kasper F.K., Mikos A.G., Ludwig J.A. Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng. B Rev. 2010, 16:351-359.
8. Sutherland R.M., McCredie J.A., Inch W.R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J. Natl. Cancer Inst. 1971, 46:113-120.
9. Sutherland R.M., Sordat B., Bamat J., Gabbert H., Bourrat B. Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res. 1986, 46:5320-5329.
10. Loessner D., Stok K.S., Lutolf M.P., Hutmacher D.W., Clements J.A., Rizzi S.C. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 2010, 31:8494-8506. 10.1016/j.biomaterials.2010.07.064.
11. Bissell M.J., Radisky D. Putting tumours in context. Nat. Rev. Cancer 2001, 1:46-54. 10.1038/35094059.
12. Petersen O.W., Rønnov-Jessen L., Howlett A.R., Bissell M.J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:9064-9068.
13. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Briand P., Damsky C., et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 1997, 137:231-245.
14. Sharma S.V., Haber D.A., Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat. Rev. Cancer 2010, 10:241-253. 10.1038/nrc2820.
15. Breslin S., O'Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov. Today 2012, 10.1016/j.drudis.2012.10.003.
16. (n.d.). http://www.cancer.gov.
17. Szakács G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5:219-234. 10.1038/nrd1984.
18. Moitra K., Lou H., Dean M. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clin. Pharmacol. Ther. 2011, 89:491-502. 10.1038/clpt.2011.14.
19. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610. 10.1016/j.cell.2007.08.006.
20. Hutmacher D.W. Biomaterials offer cancer research the third dimension. Nat. Mater. 2010, 9:90-93. 10.1038/nmat2619.
21. Frantz C., Stewart K.M., Weaver V.M. The extracellular matrix at a glance. J. Cell Sci. 2010, 123:4195-4200. 10.1242/jcs.023820.
22. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 2012, 196:395-406. 10.1083/jcb.201102147.
23. Juliano R.L., Haskill S. Signal transduction from the extracellular matrix. J. Cell Biol. 1993, 120:577-585.
24. Jang S.H., Wientjes M.G., Lu D., Au J.L.S. Drug delivery and transport to solid tumors. Pharm. Res. 2003, 20:1337-1350.
25. Kim S.-H., Turnbull J., Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. 2011, 209:139-151. 10.1530/JOE-10-0377.
26. Wozniak M.A., Chen C.S. Mechanotransduction in development: a growing role for contractility. Nat. Rev. Mol. Cell Biol. 2009, 10:34-43. 10.1038/nrm2592.
27. Samuel M.S., Lopez J.I., McGhee E.J., Croft D.R., Strachan D., Timpson P., et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011, 19:776-791. 10.1016/j.ccr.2011.05.008.
28. Janmey P.A., Miller R.T. Mechanisms of mechanical signaling in development and disease. J. Cell Sci. 2011, 124:9-18. 10.1242/jcs.071001.
29. Ng M.R., Brugge J.S. A stiff blow from the stroma: collagen crosslinking drives tumor progression. Cancer Cell 2009, 16:455-457. 10.1016/j.ccr.2009.11.013.
30. Chen L., Xiao Z., Meng Y., Zhao Y., Han J., Su G., et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 2012, 33:1437-1444. 10.1016/j.biomaterials.2011.10.056.
31. Szot C.S., Buchanan C.F., Gatenholm P., Rylander M.N., Freeman J.W. Investigation of cancer cell behavior on nanofibrous scaffolds. Mater. Sci. Eng. C 2011, 31:37-42. 10.1016/j.msec.2009.12.005.
32. Szot C.S., Buchanan C.F., Freeman J.W., Rylander M.N. 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 2011, 32:7905-7912. 10.1016/j.biomaterials.2011.07.001.
33. Zschenker O., Streichert T., Hehlgans S., Cordes N. Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair. PLoS ONE 2012, 7:e34279. 10.1371/journal.pone.0034279.
34. David L., Dulong V., Le Cerf D., Chauzy C., Norris V., Delpech B., et al. Reticulated hyaluronan hydrogels: a model for examining cancer cell invasion in 3D. Matrix Biol. 2004, 23:183-193. 10.1016/j.matbio.2004.05.005.
35. Chitcholtan K., Asselin E., Parent S., Sykes P.H., Evans J.J. Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. Exp. Cell Res. 2013, 319:75-87. 10.1016/j.yexcr.2012.09.012.
36. Gurski L.A., Jha A.K., Zhang C., Jia X., Farach-Carson M.C. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 2009, 30:6076-6085. 10.1016/j.biomaterials.2009.07.054.
37. Dangi-Garimella S., Strouch M.J., Grippo P.J., Bentrem D.J., Munshi H.G. Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression. Oncogene 2011, 30:1002-1008. 10.1038/onc.2010.485.
38. Dangi-Garimella S., Krantz S.B., Barron M.R., Shields M.A., Heiferman M.J., Grippo P.J., et al. Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer Res. 2011, 71:1019-1028. 10.1158/0008-5472.CAN-10-1855.
39. Fallica B., Maffei J.S., Villa S., Makin G., Zaman M. Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels. PLoS ONE 2012, 7:e48024. 10.1371/journal.pone.0048024.
40. Provenzano P.P., Inman D.R., Eliceiri K.W., Knittel J.G., Yan L., Rueden C.T., et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008, 6:11. 10.1186/1741-7015-6-11.
41. Provenzano P.P., Inman D.R., Eliceiri K.W., Keely P.J. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 2009, 28:4326-4343. 10.1038/onc.2009.299.
42. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906. 10.1016/j.cell.2009.10.027.
43. Genové E., Shen C., Zhang S., Semino C.E. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials 2005, 26:3341-3351. 10.1016/j.biomaterials.2004.08.012.
44. Gill B.J., Gibbons D.L., Roudsari L.C., Saik J.E., Rizvi Z.H., Roybal J.D., et al. A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res. 2012, 72:6013-6023. 10.1158/0008-5472.CAN-12-0895.
45. Sieh S., Taubenberger A.V., Rizzi S.C., Sadowski M., Lehman M.L., Rockstroh A., et al. Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment. PLoS ONE 2012, 7:e40217. 10.1371/journal.pone.0040217.
46. Loessner D., Rizzi S.C., Stok K.S., Fuehrmann T., Hollier B., Magdolen V., et al. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread. Biomaterials 2013, 34:7389-7400. 10.1016/j.biomaterials.2013.06.009.
47. Fischbach C., Chen R., Matsumoto T., Schmelzle T., Brugge J.S., Polverini P.J., et al. Engineering tumors with 3D scaffolds. Nat. Methods 2007, 4:6-11. 10.1038/NMETH1085.
48. Horning J.L., Sahoo S.K., Vijayaraghavalu S., Dimitrijevic S., Vasir J.K., Jain T.K., et al. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol. Pharm. 2008, 5:849-862.
49. Sahoo S.K., Panda A.K., Labhasetwar V. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules 2005, 6:1132-1139.
50. Rizzi S.C., Ehrbar M., Halstenberg S., Raeber G.P., Schmoekel H.G., Hagenmüller H., et al. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules 2006, 7:3019-3029. 10.1021/bm060504a.
51. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5413-5418. 10.1073/pnas.0737381100.
52. Gelain F., Bottai D., Vescovi A., Zhang S. Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures. PLoS ONE 2006, 1:e119. 10.1371/journal.pone.0000119.
53. Weiss M.S., Bernabé B.P., Shikanov A., Bluver D.A., Mui M.D., Shin S., et al. The impact of adhesion peptides within hydrogels on the phenotype and signaling of normal and cancerous mammary epithelial cells. Biomaterials 2012, 33:3548-3559. 10.1016/j.biomaterials.2012.01.055.
54. Hartgerink J.D., Beniash E., Stupp S.I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001, 294:1684-1688. 10.1126/science.1063187.
55. Schneider J.P., Pochan D.J., Ozbas B., Rajagopal K., Pakstis L., Kretsinger J. Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. J. Am. Chem. Soc. 2002, 124:15030-15037.
56. Semino C.E. Can we build artificial stem cell compartments?. J. Biomed. Biotechnol. 2003, 2003:164-169. 10.1155/S1110724303208019.
57. Zhang S., Altman M. Peptide self-assembly in functional polymer science and engineering. React. Funct. Polym. 1999, 41:91-102. 10.1016/S1381-5148(99)00031-0.
58. Zhang S., Holmes T.C., DiPersio C.M., Hynes R.O., Su X. A rich, self-complementary oligopeptide matrices support mammalian cell attachment. Biomaterials 1995, 16:1385-1393.
59. Genové E., Schmitmeier S., Sala A., Borrós S., Bader A., Griffith L.G., et al. Functionalized self-assembling peptide hydrogel enhance maintenance of hepatocyte activity in vitro. J. Cell. Mol. Med. 2009, 13:3387-3397. 10.1111/j.1582-4934.2009.00970.x.
60. Soman P., Kelber J.A., Lee J.W., Wright T.N., Vecchio K.S., Klemke R.L., et al. Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness. Biomaterials 2012, 33:7064-7070. 10.1016/j.biomaterials.2012.06.012.
61. Miroshnikova Y., Jorgens D., Spirio L., Auer M., Sarang-Sieminski A., Weaver V.M. Engineering strategies to recapitulate epithelial morphogenesis within synthetic three-dimensional extracellular matrix with tunable mechanical properties. Phys. Biol. 2011, 8:026013.
62. Mi K., Wang G., Liu Z., Feng Z., Huang B., Zhao X. Influence of a self-assembling peptide, RADA16, compared with collagen I and Matrigel on the malignant phenotype of human breast-cancer cells in 3D cultures and in vivo. Macromol. Biosci. 2009, 9:437-443. 10.1002/mabi.200800262.
63. Krause S., Maffini M.V., Soto A.M., Sonnenschein C. The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures. BMC Cancer 2010, 10:263-276. 10.1186/1471-2407-10-263.
64. Pedron S., Becka E., Harley B.A.C. Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid. Biomaterials 2013, 34:7408-7417. 10.1016/j.biomaterials.2013.06.024.
65. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013.
66. Christofori G. New signals from the invasive front. Nature 2006, 441:444-450. 10.1038/nature04872.
67. Debnath J., Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 2005, 5:675-688. 10.1038/nrc1695.
68. Weigelt B., Lo A.T., Park C.C., Gray J.W., Bissell M.J. HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res. Treat. 2010, 122:35-43. 10.1007/s10549-009-0502-2.
69. Shibue T., Weinberg R.A. Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:10290-10295. 10.1073/pnas.0908506106.
70. Dhimolea E., Maffini M.V., Soto A.M., Sonnenschein C. The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model. Biomaterials 2010, 31:3622-3630. 10.1016/j.biomaterials.2010.01.077.
71. Park C.C., Zhang H., Pallavicini M., Gray J.W., Baehner F., Park C.J., et al. β1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res. 2006, 66:1526-1535. 10.1158/0008-5472.CAN-05-3071.
72. Park C.C., Zhang H.J., Yao E.S., Park C.J., Bissell M.J. β1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res. 2008, 68:4398-4405. 10.1158/0008-5472.CAN-07-6390.
73. White D.E., Kurpios N.A., Zuo D., Hassell J.A., Blaess S., Mueller U., et al. Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004, 6:159-170.
74. Kren A., Baeriswyl V., Lehembre F., Wunderlin C., Strittmatter K., Antoniadis H., et al. Increased tumor cell dissemination and cellular senescence in the absence of β1-integrin function. EMBO J. 2007, 26:2832-2842. 10.1038/sj.emboj.7601738.
75. Bott K., Upton Z., Schrobback K., Ehrbar M., Hubbell J.A., Lutolf M.P., et al. The effect of matrix characteristics on fibroblast proliferation in 3D gels. Biomaterials 2010, 31:8454-8464. 10.1016/j.biomaterials.2010.07.046.
76. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254. 10.1016/j.ccr.2005.08.010.
77. Folkman J. Tumor angiogenesis. Cancer Med. 2000, 132-152.
78. Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat. Rev. Cancer 2006, 6:583-592. 10.1038/nrc1893.
79. Fukumura D., Jain R.K. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res. 2007, 74:72-84. 10.1016/j.mvr.2007.05.003.
80. Kimlin L.C., Casagrande G., Virador V.M. In vitro three-dimensional (3D) models in cancer research: an update. Mol. Carcinog. 2013, 52:167-182. 10.1002/mc.21844.
81. Velazquez O., Snyder R., Liu Z., Fairman R., Herlyn M. Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks. FASEB J. 2002, 16:1316-1318.
82. Chan J.M., Zervantonakis I.K., Rimchala T., Polacheck W.J., Whisler J., Kamm R.D. Engineering of in vitro 3D capillary beds by self-directed angiogenic sprouting. PLoS ONE 2012, 7:e50582. 10.1371/journal.pone.0050582.
83. Verbridge S.S., Chandler E.M., Fischbach C. Tissue-engineered three-dimensional tumor models to study tumor angiogenesis. Tissue Eng. A 2010, 16:2147-2152. 10.1089/ten.TEA.2009.0668.
84. Chen R.R., Silva E.a, Yuen W.W., Brock A.a, Fischbach C., Lin A.S., et al. Integrated approach to designing growth factor delivery systems. FASEB J. 2007, 21:3896-3903. 10.1096/fj.06-7873com.
85. Seano G., Chiaverina G., Gagliardi P.A., di Blasio L., Sessa R., Bussolino F., et al. Modeling human tumor angiogenesis in a three-dimensional culture system. Blood 2013, 121:e129-e137. 10.1182/blood-2012-08-452292.
86. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142. 10.1038/nrm1835.
87. Wodarz A., Näthke I. Cell polarity in development and cancer. Nat. Cell Biol. 2007, 9:1016-1024.
88. Wolf K., Wu Y.I., Liu Y., Geiger J., Tam E., Overall C., et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 2007, 9:893-904. 10.1038/ncb1616.
89. Oyanagi J., Ogawa T., Sato H., Higashi S., Miyazaki K. Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel. PLoS ONE 2012, 7:e53209. 10.1371/journal.pone.0053209.
90. Nguyen-Ngoc K.-V., Cheung K.J., Brenot A., Shamir E.R., Gray R.S., Hines W.C., et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E2595-E2604. 10.1073/pnas.1212834109.
91. Gurski L.A., Xu X., Labrada L.N., Nguyen N.T., Xiao L., van Golen K.L., et al. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels. PLoS ONE 2012, 7:e50075. 10.1371/journal.pone.0050075.
92. Schwartz M.P., Fairbanks B.D., Rogers R.E., Rangarajan R., Zaman H., Anseth K.S. A synthetic strategy for mimicking the extracellular matrix provides new insight about tumor cell migration. Integr. Biol. 2010, 2:32-40. 10.1039/b912438a.
93. Kraning-Rush C., Carey S., Lampi M., Reinhart-King C. Microfabricated collagen tracks facilitate single cell metastatic invasion in 3D. Integr. Biol. 2013, 5:606-616.
94. Rizvi I., Gurkan U.A., Tasoglu S., Alagic N., Celli J.P., Mensah L.B. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E1974-E1983. 10.1073/pnas.1216989110/-/DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1216989110.
95. Huang C.P., Lu J., Seon H., Lee A.P., Flanagan L.A., Kim H., et al. Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip 2009, 9:1740-1748. 10.1039/b818401a.
96. Polacheck W.J., Charest J.L., Kamm R.D. Interstitial flow influences direction of tumor cell migration through competing mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11115-11120. 10.1073/pnas.1103581108.
97. Vickerman V., Blundo J., Chung S., Kamm R.D. Design, fabrication and implementation of a novel multi-parameter control microfluidic platform for three-dimensional cell culture and real-time imaging. Lab Chip 2008, 8:1468-1477.
98. Hernández Vera R., Genové E., Alvarez L., Borrós S., Kamm R.D., Lauffenburger D., et al. Interstitial fluid flow intensity modulates endothelial sprouting in restricted Src-activated cell clusters during capillary morphogenesis. Tissue Eng. A 2009, 15:175-185. 10.1089/ten.tea.2007.0314.
99. Semino C.E., Kamm R.D., Lauffenburger D.A. Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. Exp. Cell Res. 2006, 312:289-298. 10.1016/j.yexcr.2005.10.029.
100. Shin M.K., Kim S.K., Jung H. Integration of intra- and extravasation in one cell-based microfluidic chip for the study of cancer metastasis. Lab Chip 2011, 11:3880-3887. 10.1039/c1lc20671k.
101. Cross V.L., Zheng Y., Won Choi N., Verbridge S.S., Sutermaster B.A., Bonassar L.J., et al. Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials 2010, 31:8596-8607. 10.1016/j.biomaterials.2010.07.072.
102. Zheng Y., Chen J., Craven M., Choi N.W., Totorica S., Diaz-Santana A., et al. In vitro microvessels for the study of angiogenesis and thrombosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9342-9347. 10.1073/pnas.1201240109.
103. Jeon J.S., Zervantonakis I.K., Chung S., Kamm R.D., Charest J.L. In vitro model of tumor cell extravasation. PLoS ONE 2013, 8:e56910. 10.1371/journal.pone.0056910.
104. Barkan D., Green J.E., Chambers A.F. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur. J. Cancer 2010, 46:1181-1188. 10.1016/j.ejca.2010.02.027.
105. Cox R.F., Jenkinson A., Pohl K., O'Brien F.J., Morgan M.P. Osteomimicry of mammary adenocarcinoma cells in vitro; increased expression of bone matrix proteins and proliferation within a 3D collagen environment. PLoS ONE 2012, 7:e41679. 10.1371/journal.pone.0041679.
106. Pathi S.P., Lin D.D.W., Dorvee J.R., Estroff L.A., Fischbach C. Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis. Biomaterials 2011, 32:5112-5122. 10.1016/j.biomaterials.2011.03.055.
107. Birgersdotter A., Sandberg R., Ernberg I. Gene expression perturbation in vitro - a growing case for three-dimensional (3D) culture systems. Semin. Cancer Biol. 2005, 15:405-412. 10.1016/j.semcancer.2005.06.009.
108. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nat. Rev. Cancer 2004, 432:332-337.
109. Mueller M.M., Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004, 4:839-849. 10.1038/nrc1477.
110. Leeper A.D., Farrell J., Williams L.J., Thomas J.S., Dixon J.M., Wedden S.E., et al. Determining tamoxifen sensitivity using primary breast cancer tissue in collagen-based three-dimensional culture. Biomaterials 2012, 33:907-915. 10.1016/j.biomaterials.2011.10.028.
111. Truong H.H., de Sonneville J., Ghotra V.P.S., Xiong J., Price L., Hogendoorn P.C.W., et al. Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens. Biomaterials 2012, 33:181-188. 10.1016/j.biomaterials.2011.09.049.
112. Lan S.-F., Starly B. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol. Appl. Pharmacol. 2011, 256:62-72. 10.1016/j.taap.2011.07.013.
113. Yang Z., Zhao X. A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell-scaffold interaction and chemotherapeutic resistance of anticancer drugs. Int. J. Nanomedicine 2011, 6:303-310. 10.2147/IJN.S15279.
114. Dhiman H.K., Ray A.R., Panda A.K. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials 2005, 26:979-986. 10.1016/j.biomaterials.2004.04.012.
115. Markovitz-bishitz Y., Tauber Y., Afrimzon E., Zurgil N., Sobolev M., Shafran Y., et al. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids. Biomaterials 2010, 31:8436-8444. 10.1016/j.biomaterials.2010.07.050.
116. Xu F., Celli J., Rizvi I., Moon S., Hasan T., Demirci U. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform. Biotechnol. J. 2011, 6:204-212. 10.1002/biot.201000340.
117. Sodunke T.R., Turner K.K., Caldwell S.A., Mcbride K.W., Reginato M.J., Moses H. Micropatterns of Matrigel for three-dimensional epithelial cultures. Biomaterials 2007, 28:4006-4016. 10.1016/j.biomaterials.2007.05.021.
118. Deiss F., Mazzeo A., Hong E., Ingber D.E., Derda R., Whitesides G.M. Platform for high-throughput testing of the effect of soluble compounds on 3D cell cultures. Anal. Chem. 2013, 85(17):8085-8094. 10.1021/ac400161j.
119. Adanja I., Debeir O., Mégalizzi V., Kiss R., Warzée N., Decaestecker C. Automated tracking of unmarked cells migrating in three-dimensional matrices applied to anti-cancer drug screening. Exp. Cell Res. 2010, 316:181-193. 10.1016/j.yexcr.2009.10.004.
120. Li Q., Chen C., Kapadia A., Zhou Q., Harper M.K., Schaack J., et al. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. J. Biomol. Screen. 2011, 16:141-154. 10.1177/1087057110392995.
121. Kanapathipillai M., Brock A., Ingber D.E. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv. Drug Deliv. Rev. 2014, 10.1016/j.addr.2014.05.005.
122. Chen Y., Gao D.-Y., Huang L. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv. Drug Deliv. Rev. 2014, 10.1016/j.addr.2014.05.009.
123. Egeblad M., Rasch M.G., Weaver V.M. Dynamic interplay between the collagen scaffold and tumor evolution. Curr. Opin. Cell Biol. 2010, 22:697-706. 10.1016/j.ceb.2010.08.015.
124. Ananthanarayanana B., Kima Y., Kumara S. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials 2011, 32:7913-7923.
125. Lianga Y., Jeonga J., DeVoldera R.J., Chac C., Wangd F., Tonge Y.W., et al. A cell-instructive hydrogel to regulate malignancy of 3D tumor spheroids with matrix rigidity. Biomaterials 2011, 32:9308-9315.